These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20597655)

  • 1. Scenario 1: a patient with hospital-acquired bacterial pneumonia--introduction to clinical trial design issues.
    Gilbert DN
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S10-1. PubMed ID: 20597655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scenario 2: A patient with ventilator-associated bacterial pneumonia--introduction to clinical trial design issues.
    Gilbert DN
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S100-2. PubMed ID: 20597656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.
    Gilbert DN
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S121-2. PubMed ID: 18986276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia.
    Kollef MH
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S29-35. PubMed ID: 20597668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-acquired pneumonia: recent advances in diagnosis, microbiology and treatment.
    Bruchhaus JD; McEachern R; Campbell GD
    Curr Opin Pulm Med; 1998 May; 4(3):180-4. PubMed ID: 9675521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective.
    Barriere SL
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S4-9. PubMed ID: 20597670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design.
    Niederman MS
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S12-7. PubMed ID: 20597660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective.
    Laessig KA
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S117-9. PubMed ID: 20597659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.
    Sorbello A; Komo S; Valappil T; Nambiar S
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S36-41. PubMed ID: 20597669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
    Bradley JS
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI; Anzueto A
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trends in the treatment of pneumonia].
    Grassi V; Romanelli G
    Recenti Prog Med; 1999; 90(7-8):373-9. PubMed ID: 10429515
    [No Abstract]   [Full Text] [Related]  

  • 13. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia.
    Bartlett JG; Barie PS; Niederman MS; Wunderink RG
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-3. PubMed ID: 20597654
    [No Abstract]   [Full Text] [Related]  

  • 15. Considerations in undertaking a clinical development program for hospital-acquired bacterial pneumonia and/or ventilator-associated bacterial pneumonia.
    Talbot GH
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S144-9. PubMed ID: 20597665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial design and consequences for drug development for community-acquired pneumonia: an industry perspective.
    Tillotson GS; Echols RM
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S237-40. PubMed ID: 18986296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial treatment of hospital-acquired pneumonia.
    Fagon JY; Chastre J
    Clin Chest Med; 2005 Mar; 26(1):97-104. PubMed ID: 15802171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The therapy of nosocomial pneumonia].
    Lode H; Schaberg T; Raffenberg M
    Dtsch Med Wochenschr; 1997 Jan; 122(4):93-6. PubMed ID: 9072478
    [No Abstract]   [Full Text] [Related]  

  • 19. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(The JRS Guideline for the management of hospital-acquired pneumonia in adults)].
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2578-83. PubMed ID: 19051751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.